Spruill W J, McCall C Y, Francisco G E
Am J Hosp Pharm. 1985 Nov;42(11):2506-9.
The in vitro inactivation of tobramycin when combined with each of six cephalosporins in samples of human serum was investigated. Each of six cephalosporins (cefazolin sodium, cefoxitin sodium, cefamandole nafate, moxalactam disodium, cefoperazone sodium, and cefotaxime sodium) was added to human serum samples containing tobramycin sulfate 8 micrograms/mL to produce final cephalosporin concentrations of approximately 250 and 1000 micrograms/mL. Duplicate solutions were prepared and stored at either 0 or 21 degrees C. Solutions containing tobramycin 8 micrograms/mL alone and with carbenicillin disodium in four concentrations were prepared as controls. Samples were assayed using a fluorescence polarization immunoassay (TDX) at 0, 2, 4, 8, 12, 24, and 48 hours to determine tobramycin concentration; two of the carbenicillin-tobramycin solutions were frozen immediately for assay 53 hours later. Tobramycin concentrations in the admixtures were compared with those in tobramycin reference samples. At both temperatures, samples containing tobramycin with cefamandole 250 micrograms/mL or cefotaxime 250 micrograms/mL showed less than 10% inactivation of tobramycin for at least 48 hours. At 0 degrees C, tobramycin retained greater than 90% activity when combined with cefoperazone 250 and 1000 micrograms/mL. In samples containing cefazolin 250 micrograms/mL at 0 degrees C and cefoperazone 250 micrograms/mL at 21 degrees C, tobramycin was stable for 24 hours. Only samples containing moxalactam stored at 21 degrees C showed greater than 16% inactivation of tobramycin at 48 hours. Under these study conditions, tobramycin is only moderately inactivated in vitro when combined with clinically achievable concentrations of the tested cephalosporins (excluding moxalactam) and then stored for up to 48 hours.(ABSTRACT TRUNCATED AT 250 WORDS)
研究了妥布霉素在人血清样本中与六种头孢菌素分别联合时的体外失活情况。将六种头孢菌素(头孢唑林钠、头孢西丁钠、头孢孟多酯钠、拉氧头孢二钠、头孢哌酮钠和头孢噻肟钠)分别添加到含有8微克/毫升硫酸妥布霉素的人血清样本中,使头孢菌素的最终浓度约为250和1000微克/毫升。制备了一式两份的溶液,并分别储存在0或21摄氏度。制备了单独含有8微克/毫升妥布霉素以及含有四种浓度羧苄西林二钠的溶液作为对照。在0、2、4、8、12、24和48小时使用荧光偏振免疫分析法(TDX)对样本进行检测以确定妥布霉素浓度;其中两份羧苄西林 - 妥布霉素溶液立即冷冻,53小时后进行检测。将混合液中的妥布霉素浓度与妥布霉素参考样本中的浓度进行比较。在两个温度下,含有250微克/毫升头孢孟多或250微克/毫升头孢噻肟的妥布霉素样本在至少48小时内妥布霉素失活小于10%。在0摄氏度时,妥布霉素与250和1000微克/毫升头孢哌酮联合时保留大于90%的活性。在0摄氏度含有250微克/毫升头孢唑林的样本以及21摄氏度含有250微克/毫升头孢哌酮的样本中,妥布霉素在24小时内保持稳定。仅在21摄氏度储存的含有拉氧头孢的样本在48小时时妥布霉素失活大于16%。在这些研究条件下,当妥布霉素与临床可达到浓度的受试头孢菌素(不包括拉氧头孢)联合,然后储存长达48小时时,其在体外仅中度失活。(摘要截短为250字)